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Abstract. In this paper, a delay differential equations (DDEs) model of leukemia is introduced and its dynamical properties are
investigated in comparison with the modified fractional-order system where the Caputo’s derivative is used. The model takes
into account three types of division that a stem-like cell can undergo and cell competition between healthy and leukemia cell
populations. The action of the immune system on the leukemic cell populations is also considered. The stability properties of the
equilibrium points are established through numerical results and the differences between the two types of approaches are discussed.
Medical conclusions are drawn in view of the obtained numerical simulations.
INTRODUCTION
Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder characterized by the Philadelphia (Ph) chro-
mosome translocation. This translocation causes the transcription of a constitutively active oncogenic enzyme with
tyrosine kinase activity: BCR-ABL ([15]). Research in the last decades has ascertained that BCR-ABL is the cause to
the CML pathogenesis and that constitutive tyrosine kinase activity is central to BCR-ABL’s ability to alter normal
hematopoietic cells into leukemic cells ([12]).
Most of the cases are diagnosed during an initial chronic phase characterized by increased proliferation and the
accumulation of immature myeloid cells over several years. If untreated, CML inevitably progresses to an accelerated
phase and/or blast phase. The treatment of CML has been revolutionized by the advent of specific tyrosine kinase
inhibitors (TKI). TKI selectively inhibits BCR-ABL action and, consequently, repress the tyrosine kinase activity.
The most important TKI is Imatinib, which has a very good outcome if the treatment is not interrupted ([26]).
It is generally assumed that the immune system plays an essential role in tumor evolution. Researches in cancer
immunology imply that both innate and adaptive immunity are implicated in the defense systems against cancer. In
CML, leukemic cells express antigens that are immunogenic and can be recognized by cytotoxic T cells (or CD8+ T
cells), which are able to eliminate leukemic stem cells (LSCs) ([34]). In [9], the authors claim that some CML patients
under imatinib-induced remission develop an anti-leukemia immune response involving both CD4+ and CD8+ T
cells. New advances in cancer immunotherapy suggest that the immune system can be used as a tool to prevent or cure
cancer [36]. Consequently, immunotherapy should be considered as a complementary therapy, in order to increase
the effectiveness of the immune response against cancer. T-cell based therapies have been shown to boost the body’s
ability to fight cancers as leukemia, lymphoma and breast cancer [13]. Therefore a model that includes T cell dynamics
may serve to enhance the potential immunotherapy treatments of CML.
There is a vast literature on mathematical modeling the normal and pathologic hematopoiesis ([1], [6], [10], [11],
[17], [18], [32], [33]). In some papers, CML models with competition between cell lines are studied using stochastic
differential equations ([7], [31]) while in others ordinary differential equations (ODEs) are used [24], [16], [25], [14].
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However, because of the complexity of the hematopoietic system, ODEs models cannot always capture the rich variety
of dynamics observed in real life. An intermediate approach is the use of delay differential equations (DDEs) models,
which exhibit more complex dynamical behaviors (see, for example [2]).
Some models that specifically study the immune response to CML are [21], [5], [28] and [27]. In [21], Kim et
al. analyzed a high order DDEs model to account for the role of anti-leukemia specific response in CML dynamics
and concluded that the anti-leukemia T cell response may help maintain remission under Imatinib therapy. In [5], the
authors analyzed a DDEs model for the dynamics of CML cells and effectors T cells considering Imatinib therapy
and immunotherapy. The focus in the paper [28] is on analyzing a DDE model in order to elucidate the transition of
leukemia from the stable chronic phase to the unstable accelerated and acute phases. In [27], Moore and Li devise
an ODE model and examine which parameters of the model are most important in the success or failure of cancer
remission.
The DDEs model we present in Section 2 follows the lines of the models for leukemia developed by Mackey
and collaborators ([6], [11], [30]) and is part of a larger study of Halanay and colleagues about CML ([4], [8], [17],
[18], [32], [33]). One of the novelties in this study is the consideration of three types of division that a stem-like cell
can undergo: asymmetric division, symmetric self-renewal and differentiation ([35]). The DDEs system models the
interaction between healthy cell populations, leukemic cell population and active T cells and it consists of a strongly
nonlinear five-dimensional system of delay differential equations.
Recently, fractional differential models have been extensively used in different fields, such as physics, biology,
chemical technology and economy ([29], [20]). Due to the fact that fractional-order equations are naturally related to
systems with memory, which exists in most biological systems, several papers have analyzed the qualitative properties
of fractional-order biological models (see e.g. [3]). Based on the reasoning above and because adding a supplementary
memory to the DDEs model for CML might be more in line with the real life situation, we then present the fractional-
order DDEs model for CML and realise a comparison between the dynamical properties of the two models.
In the following section, the delay competition model of CML, which was first introduced in [32] (see also [8]),
is presented and explained. Based on this model, in Section 3 we introduce the fractional-order DDEs system for
CML. Section 4 presents numerical results and simulations, which are then discussed and interpreted from a medical
point of view in Section 5.
THE DDE MODEL FOR CML AND EQUILIBRIUM POINTS
The mathematical model presented in this section consists of a system of strongly nonlinear differential equations
with five time lags and five state variables. The time delays represent the duration of the cell cycle (τ1 and τ3), the
time period needed for differentiation into the leukocyte line (τ2 and τ4) and the time period needed for the naive T
cells to finish the minimal developmental program of n1 cell divisions (τ5 = n1τ, where τ is duration of one T cell
division). In this model it is assumed that the dynamics of healthy and leukemic cell populations are similar and the
only notable difference is in the value of the parameters. Consequently, the subscript of the parameters for the healthy
cells is denoted with “h” and the subscript for the abnormal cells is denoted with “l”. Also, the third and the fourth
equations are similar with the first and the second ones. Three types of division are taken into consideration in this
model: asymmetric division (η1), symmetric differentiation (η2) and self-renewal (1 − η1 − η2).
The state variables are five cell populations: healthy stem-like and mature (x1and x2), leukemic stem-like and
mature (x3and x4) and anti-leukemic T cells involving both CD4+ and CD8+ T cells (x5). The dynamics of these
populations in CML is described by the following system
x˙1 = f1(x1, x2, x3, x4, x1τ1 , x2τ1 , x3τ1 , x4τ1 )
x˙2 = f2(x2, x1τ2 , x2τ2 , x4τ2 )
x˙3 = f3(x1, x2, x3, x4, x5, x1τ3 , x2τ3 , x3τ3 , x4τ3 )
x˙4 = f4(x3, x4, x5, x2τ4 , x3τ4 , x4τ4 )
x˙5 = f5(x4, x5, x4τ5 , x5τ5 )
(1)
where
f1 = −γ1hx1 − (η1h + η2h)kh(x2 + x4)x1 − (1 − η1h − η2h)βh(x1 + x3)x1+
+2e−γ1hτ1 (1 − η1h − η2h)βh(x1τ1 + x3τ1 )x1τ1 + η1he−γ1hτ1 kh(x2τ1 + x4τ1 )x1τ1
f2 = −γ2hx2 + Ah(2η2h + η1h)kh(x2τ2 + x4τ2 )x1τ2
f3 = −γ1lx3 − (η1l + η2l)kl(x2 + x4)x3 − (1 − η1l − η2l)βl(x1 + x3)x3+
+2e−γ1lτ3 (1 − η1l − η2l)βl(x1τ3 + x3τ3 )x3τ3+
+η1le−γ1lτ3 kl(x2τ3 + x4τ3 )x3τ3 − b1x3x5l1(x3 + x4)
f4 = −γ2lx4 + Al(2η2l + η1l)kl(x2τ4 + x4τ4 )x3τ4 − b2x4x5l1(x3 + x4)
f5 = a1 − a2x5 − a3x5l2(x4) + 2n1 a4x5τ5 l2(x4τ5 )
(2)
We denote Xτ = X(t − τ), where X = (x1, x2, x3, x4, x5). The history is introduced through:
X(θ) = ϕ(θ), θ ∈ [−τmax, 0], τmax = max(τ1, τ2, τ3, τ4, τ5). (3)
Two feedback rates are considered in the model: the rate of self-renewal β(x) = β0
θm1
θm1 +x
m and the rate of differentiation
(through symmetric or asymmetric division) k(x) = k0
θn2
θn2+x
n . Because self-renewal is activated by signals from stem
cell population and differentiation is activated by signals from mature cell population, it is assumed that β depends on
the sum of stem cell populations (x1 + x3), while k depends on the sum of mature cell population (x2 + x4). In this way,
competition between healthy and CML cell populations is considered here (see also [33]).
In this model, γ1 and γ2 are mortality rates, β0 and k0, the maximal rates of self-renewal, respectively of asym-
metric division or differentiation into leukocyte line, θ1 and θ2 the values for which β, respectively k attains half of
their maximum value, A an amplification factor of mature cells due to differentiation, m is the parameter controlling
the sensitivity of the rate β to changes in the size of stem populations in G0 and n is the parameter controlling the
sensitivity of the rate k to changes in the size of mature population.
The fifth equation of the system models the anti-leukemia T cell immune response. We assume that after encoun-
tering a leukemic cell, a T cell has two alternatives: either inhibits the leukemic cell and activates a feedback function
to stimulate the production of new T cells, or it is inhibited itself by the leukemic cell.
The interaction between T cells and CML cells was modeled through the functions l1(y) = 1b3+y and l2(y) =
y
b4+y2
.
Hence, the last terms of the third and fourth equations stand for the inhibition of leukemic cells by anti-leukemia T
cells. The function l1(y) was chosen starting from the assumption that the inhibition of the leukemic cell populations
by the immune cells increases with the number of CML cells up to a certain level and then reaches a maximal value
of inhibition. A further increase in the leukemic population will not modify this value.
As CML cell population stimulates anti-leukemia immune response only if leukemia cell population has values
in a certain range, called ”the optimal load zone” (see [21]) and inhibits the immune response if it exceeds a certain
threshold value, to model the influence of CML cell population on T cell evolution, the feedback function l2(y) was
chosen. Consequently, the third and the fourth terms of the fifth equation represents the rate at which naive T cells
leave and re-enter the effector state after finishing the minimal developmental program of n1 cell divisions, due to
antigen stimulation. These terms reflect the process of production of T cells influenced by the CML cells.
The following parameters are related to the evolution of T cell population: b1 represents the loss of leukemic
stem cells due to cytotoxic T cells; b2 is the loss of mature leukemic leukocytes due to cytotoxic T cells; b3 represents
a standard half-saturation in a Michaelis-Menten law l1(y); b4 is a standard half-saturation in a feedback function l2(y);
a1 represents the anti-leukemia T-cell natural supply rate; a2 represents the anti-leukemia T-cell death rate; a3 is the
probability that a T cell survives the encounter with a leukemia cell; a4 represents the coefficient of influence of the
regulatory process; n1 is the number of antigen depending divisions.
System (1) has four possible types of equilibria with non-negative components, namely: E0 = (0, 0, 0, 0, x∗5),
E1 = (x∗1, x
∗
2, 0, 0, x
∗
5), E2 = (x
∗∗
1 , x
∗∗
2 , x
∗∗
3 , x
∗∗
4 , x
∗∗
5 ) and E3 = (0, 0, x˜3, x˜4, x˜5), corresponding, from a medical point of
view, to an extinction phase, to a healthy situation, to a chronic and respectively to an aggravated phase. Note that
depending on the parameters values, the system can exhibit one or more equilibria of type E3 (E3.i, i = 1, p - where
the value of p depends on the biologically relevant range for cell populations).
The positive components of the equilibria E1 satisfy:
γ1h + [η1h(1 − e−γ1hτ1 ) + η2h]kh(x∗2) − (1 − η1h − η2h)(2e−γ1hτ1 − 1)βh(x∗1) = 0
−γ2hx∗2 + Ah(2η2h + η1h)kh(x∗2)x∗1 = 0a1 − a2x∗5 = 0
and the positive components of E3 satisfy
γ1l + [η1l(1 − e−γ1lτ3 ) + η2l]kl(x˜4) − (1 − η1l − η2l)(2e−γ1lτ3 − 1)βl(x˜3) − γ1 x˜3 x˜5l1(x˜3 + x˜4) = 0
−γ2l x˜4 + Al(2η2l + η1l)kl(x˜4)x˜3 − b2 x˜4 x˜5l1(x˜2 + x˜4) = 0
a1 − a2 x˜5 − x˜5l2(x˜4)(a3 + 2n1 a4) = 0
For a detailed theoretical analysis of the stability properties of the equilibrium points, please see [8] and [4].
THE FRACTIONAL-ORDER DDE MODEL FOR CML
In general, three different definitions of fractional derivatives, which are in general non-equivalent, are widely used:
the Gru¨nwald-Letnikov derivative, the Riemann-Liouville derivative and the Caputo derivative (see for example [29]).
The main advantage of the Caputo derivative is that it only requires initial conditions given in terms of integer-
order derivatives, representing well-understood features of physical situations and thus making it more applicable to
real world problems. Highly remarkable scientific books which provide the main theoretical tools for the qualitative
analysis of fractional-order dynamical systems, and at the same time, show the interconnection as well as the contrast
between classical differential equations and fractional differential equations, are [29], [20], [22].
In the following, let us give the definition of the Caputo derivative and introduce the fractional-order DDEs
system for CML.
Definition 1 For a continuous function f , with f ∈ L1loc(R+), the Caputo fractional-order derivative of order
q ∈ (0, 1) of f is defined by
cDq f (t) =
1
Γ(1 − q)
∫ t
0
(t − s)−q f ′(s)ds ,
where the gamma function is defined, as usual, as Γ(z) =
∫ ∞
0 e
−ttz−1dt .
Remark 2 When q→ 1, the fractional order derivative cDq f (t) converges to the integer-order derivative f ′(t).
The fractional order DDE model for CML using the Caputo derivative is
cDqx1 = f1(x1, x2, x3, x4, x1τ1 , x2τ1 , x3τ1 , x4τ1 )
cDqx2 = f2(x2, x1τ2 , x2τ2 , x4τ2 )
cDqx3 = f3(x1, x2, x3, x4, x5, x1τ3 , x2τ3 , x3τ3 , x4τ3 )
cDqx4 = f4(x3, x4, x5, x2τ4 , x3τ4 , x4τ4 )
cDqx5 = f5(x4, x5, x4τ5 , x5τ5 ).
(4)
Although the stationary points of the fractional-order DDEs system (4) are the same as in the case of the DDEs
system (1), regarding their stability properties, things might be much different ([19]). Nevertheless, as for fractional-
order differential equations with time-delay only finite time stability results are known until now (see [23], [37]) and
the general stability theory is not yet developed, in the following section, the dynamical behavior of the DDE model
and its fractional counterpart will be analyzed and compared in view of the numerical results and simulations.
NUMERICAL SIMULATIONS
In this section, for the healthy cell populations we use the values of the parameters from [11], modifying some
values of the CML cells parameters in view of medical evidences attesting that the values of leukemic parameters
are increased or decreased in the case of leukemia. Accordingly, we consider for leukemic cells a smaller fraction of
asymmetric division, a bigger fraction of self-renewal, lower rates of apoptosis for stem and mature cells, a bigger
rate of self-renewal of stem cells, a bigger rate of asymmetric division or differentiation of stem cells and a bigger
TABLE 1. Equilibrium points for the two configurations of parameters
Equilibrium Configuration 1 Configuration 2
E0 (0, 0, 0, 0, 13.04) (0, 0, 0, 0, 13.04)
E1 (0.13, 4.46, 0, 0, 13.04) (0.13, 4.46, 0, 0, 13.04)
E2 (0.09, 0.23, 0.06, 27.76, 25.76) (0.15, 0.25, 0.004, 32.04, 22.98)
E3.1 (0, 0, 0.06, 27.61, 25.88) (0, 0, 0.92, 177.86, 14.18)
E3.2 (0, 0, 0.56, 62.46, 16.88) (0, 0, 0.004, 31.98, 23.01)
amplification factor of mature cells. Furthermore, we considered that healthy cells have a propensity to asymmetric
division, while CML cells have a predilection to self renewal ([35]). Obviously, as these values should be correlated
with the features of the patient and his disease, there are many possible configurations of parameter space.
In all simulations, we choose the same set of values for the following parameters: β0h = 1.77 · days−1, k0h =
0.1 · days−1 , θ1h = θ1l = 0.5 · 106cells kg−1, θ2h = θ2l = 36 · 108cells kg−1, m = 4, n = 3, γ1h = 0.1 · days−1,
η1h = 0.7, η1l = 0.1, η2h = 0.1, η2l = 0.7, γ2h = 2.4, Ah = 829, b1 = 0.3, b2 = 0.6, b3 = 36, b4 = 36, a1 = 3,
a2 = 0.23, a3 = 0.3,a4 = 0.9, n1 = 2, τ1 = 2.8, τ2 = 3.5, τ3 = 2.1, τ4 = 2.8, τ5 = 1.4. For the rest of the parameters,
in the following simulations, we consider two configurations of parameters describing two different forms of CML:
configuration 1, with β0l = 2, k0l = 0.4, γ1l = 0.04, γ2l = 1.5, Al = 2764.8 and configuration 2, corresponding to a
more serious disease, with β0l = 2.27, k0l = 0.8, γ1l = 0.01, γ2l = 0.15, Al = 5529.6. The values of the equilibrium
points for the two configurations are listed in the table below.
Because the aim of this study is to compare the dynamical behavior of the model’s trajectories in the case of the
DDEs model and the modified fractional counterpart, in the following, numerical results and simulations pertaining to
the stability properties of equilibria of type E1, E2,and E3 will be presented. The history used in examples is constant
and is taken in a neighborhood of the non trivial steady state.
FIGURE 1. Configuration 1. Dynamics of hematopoietic populations starting from the neighborhood of E1 for the integer-order
DDEs model (left) and for the fractional-order DDEs model with q = 0.6 (right).
FIGURE 2. Configuration 1. Dynamics of hematopoietic populations starting from the neighborhood of E2 for the integer-order
DDEs model (left) and for the fractional-order DDEs model with q = 0.6 (right).
FIGURE 3. Configuration 1. Dynamics of hematopoietic populations starting from the neighborhood of E3.1 for the integer-order
DDEs model (left) and for the fractional-order DDEs model with q = 0.6 (right).
FIGURE 4. Configuration 1. Dynamics of hematopoietic populations starting from the neighborhood of E3.2 for the integer-order
DDEs model (left) and for the fractional-order DDEs model with q = 0.6 (right).
FIGURE 5. Configuration 2. Dynamics of hematopoietic populations starting from the neighborhood of E1 for the integer-order
DDEs model (left) and for the fractional-order DDEs model with q = 0.6 (right).
FIGURE 6. Configuration 2. Dynamics of hematopoietic populations starting from the neighborhood of E2 for the integer-order
DDEs model (left) and for the fractional-order DDEs model with q = 0.6 (right).
FIGURE 7. Configuration 2. Dynamics of hematopoietic populations starting from the neighborhood of E3.1 for the integer-order
DDEs model (left) and for the fractional-order DDEs model with q = 0.6 (right).
FIGURE 8. Configuration 2. Dynamics of hematopoietic populations starting from the neighborhood of E3.2 for the integer-order
DDEs model (left) and for the fractional-order DDEs model with q = 0.6 (right).
CONCLUDING REMARKS
For both configurations of parameters, we found that equilibrium E1 is stable and as the fractional order q decreases
the evolution is slower; equilibrium E2 is unstable, and as the fractional order decreases, one can notice that the time
period needed for the amount of the leukemic populations to rise up to a certain level become longer (2−3 months for
q = 1 and 5 − 6 months for q = 0.6 in the case of the first configuration and around 1 months for q = 1 and 3 months
for q = 0.6 for the second configuration). For the two configurations of parameters values, two steady states of type
E3 can coexist: the first one (denoted E3.1) can be either stable or unstable; the second one (denoted E3.2) is always
unstable. Equilibrium E3.1 is unstable for the first configuration and stable for the second one, but the time evolution
is very similar in the DDEs model and its fractional counterpart; equilibrium E3.2 is unstable in both configurations, it
seems to be attracted by E3.1 for the second configuration and as the fractional order decreases, a very similar behavior
as in the case of E2 is noticed.
Consequently, an important conclusion can be drawn from the numerical simulations, as medical evidences
regarding CML attest that the disease typically begins in the chronic phase and progresses to an accelerated phase
over the course of several years, not only in few months. Hence, the results above are important findings suggesting
that the introduction of fractional derivative into the DDEs system with a small fractional order q, might bring a more
accurate representation of the reality into the model and improve it.
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